Who We Are

Leadership Team

  • Eugene A. Baker Chief Executive Officer and Co-Founder

    Gene brings to TruMed more than 25 years of healthcare, supply chain, and start-up experience. Most recently, Gene served as VP of Strategy and Business Innovation, Dispensing (Pyxis), for CareFusion (NYSE: CFN), a leader in hospital medication dispensing and supply management systems. Gene's start-up experiences include Nature's Cure, OmniCell Technologies (Nasdaq: OMCL), HeartScan Imaging, and Hudson Bend Corp., among others. When he is not working on technology and business innovation and growth, you can probably find Gene coaching or watching youth soccer or umpiring Little League baseball in the Bay Area. Gene is a licensed Professional Engineer and earned a Master of Business Administration from Stanford University and a Bachelor of Science degree from the US Military Academy.

  • Thomas M. Netzer General Manager, Vaccine Systems

    Tom comes to TruMed with more than 25 years of experience working in the vaccines and small-molecule pharmaceuticals industry, including nearly two decades working in Global Enterprise Leadership and Product Launch roles at Merck. Earlier in his career, Tom held various product manager and business development positions at Wyeth-Lederle Vaccines & Pediatrics and Lederle Laboratories. He earned a Master of Business Administration with honors, at the Fox School of Business and Management, Temple University and served as a Commissioned Officer in the US Army, earning numerous awards, including the Bronze Star Medal.

  • Peter Dickstein Vice President of Strategy and Chief Financial Officer

    Peter has 25 years of experience building, operating and realizing enterprise value for companies. He has served as CFO for several medical device and healthcare companies including EndoTex (acquired by Boston Scientific) and as consulting CFO for Intuitive Surgical (ISRG) and Zeltiq Aesthetics(ZLTQ). His healthcare industry experience also includes numerous corporate development and finance advisory roles for Cardinal Health (CAH), Pyxis (acquired by CareFusion), mscripts, and others. An entrepreneur at heart, Dickstein was founder and CEO of eProsper, a patented cloud-based capitalization management company, which was acquired by Silicon Valley Bancorp and Solium Capital. He earned a Master of Business Administration at the Wharton School of Business at the University of Pennsylvania.

Board of Directors

  • David J. Williams

    Over the course of his 30-year career, Mr. Williams played a vital role in growing Sanofi Pasteur into the world`s largest vaccine company. He served as Chairman and CEO of Sanofi Pasteur, S.A., the vaccines business of Sanofi-Aventis. During his tenure, the organization grew from 100 employees and sales of just over $5 million to 11,000 employees and more than $6 billion in revenue. He was chairman of the company's board of directors and a member of the Supervisory Board of Sanofi Pasteur MSD, a 50-50 joint venture with Merck & Co. Early in his career, Dave spent more than five years at PricewaterhouseCoopers in their Audit and Healthcare Consulting Group.

  • Michael de Anda

    Mr. de Anda is the founder of de Anda Capital LLC, a Bay area based family office. He has over twenty years experience investing in growth companies. He currently serves on the boards of Lecorpio, Veri-tax, Therapydia and PRE Diversified Holdings. Mr. de Anda earned his C.P.A. in Illinois. He holds a Bachelors degree in Accounting from DePaul University and a Master of Business Administration from Stanford University's Graduate School of Business.

  • Michael O'Connell

    Michael F. O'Connell is the head Managing Director at M2O, Inc. He oversees the assessment of investment opportunities and reviews the ongoing performance of portfolio companies. Michael also sits on the board of American Biosurgical, Inc. For the bulk of his career, Michael was the Managing Director and President of Anhalt, O'Connell & Steffanci Inc., a Los Angeles-based investment management firm with almost $1 billion under management. In 1992, Michael purchased the National Lines Bureau, a ship mooring company operating in the Los Angeles and Long Beach harbors, the largest commercial port in America. That initial investment spawned several others and Michael soon shifted his focus from investment management to venture capital. Today, he leads M2O with a portfolio of more than 30 companies. Michael holds a B.A., with high honors, from Harvard College and an MBA from Harvard Business School.

  • Eugene A. Baker

    Gene brings to TruMed more than 25 years of healthcare, supply chain, and start-up experience. Most recently, Gene served as VP of Strategy and Business Innovation, Dispensing (Pyxis), for CareFusion (NYSE: CFN), a leader in hospital medication dispensing and supply management systems. Gene's start-up experiences include Nature's Cure, OmniCell Technologies (Nasdaq: OMCL), HeartScan Imaging, and Hudson Bend Corp., among others. When he is not working on technology and business innovation and growth, you can probably find Gene coaching or watching youth soccer or umpiring Little League baseball in the Bay Area. Gene is a licensed Professional Engineer and earned a Master of Business Administration from Stanford University and a Bachelor of Science degree from the US Military Academy.